Shri Ganesh Vinayak Medical Science Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 16-11-2024
- Paid Up Capital ₹ 8.00 M
as on 16-11-2024
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.68 Cr
as on 16-11-2024
- Revenue 32.02%
(FY 2023)
- Profit 66.23%
(FY 2023)
- Ebitda 88.34%
(FY 2023)
- Net Worth 13.63%
(FY 2023)
- Total Assets 14.33%
(FY 2023)
About Shri Ganesh Vinayak Medical Science
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹8.68 Cr.
Anil Gupta, Charudutt Kalamkar, Vinay Jaiswal, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110CT2013PTC000761
- Company No.
000761
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shri Ganesh Vinayak Medical Science?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Gupta  | Director | 21-Mar-2013 | Current |
| Charudutt Kalamkar | Director | 21-Mar-2013 | Current |
| Vinay Jaiswal | Director | 29-Mar-2013 | Current |
| Amrita Mukherjee | Director | 24-May-2021 | Current |
Financial Performance of Shri Ganesh Vinayak Medical Science.
Shri Ganesh Vinayak Medical Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.02% increase. The company also saw a substantial improvement in profitability, with a 66.23% increase in profit. The company's net worth Soared by an impressive increase of 13.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Ganesh Vinayak Medical Science?
In 2023, Shri Ganesh Vinayak Medical Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Apr 2022 | ₹4.00 M | Open |
Others Creation Date: 04 Dec 2014 | ₹8.28 Cr | Open |
How Many Employees Work at Shri Ganesh Vinayak Medical Science?
Shri Ganesh Vinayak Medical Science has a workforce of 51 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Ganesh Vinayak Medical Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Ganesh Vinayak Medical Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
